Treatment of Uncomplicated Falciparum Malaria in Southern Vietnam: Can Chloroquine or Sulfadoxine-Pyrimethamine Be Reintroduced in Combination with Artesunate?

Clinical Infectious Diseases

Volumn 37, Issue 11, 2003, Pages 1461-1466

  Huong, Nguyen Mai ^a   Davis, Timothy M E ^b,c   Cox Singh, Janet ^d   Hewitt, Sean ^b   Toan, Tran Quoc ^a   Kim, Tran Bach ^a   Hanh, Nguyen Thi ^a   Phuong, Vo Nhu ^a   Nhan, Doan Hanh ^a   Cong, Le Dinh ^a  

^a Inst Malariology   (Viet Nam)

^b MINISTRY OF HEALTH   (Viet Nam)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^d UNIVERSITI MALAYSIA SARAWAK   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; CHLOROQUINE; FANSIDAR; MEFLOQUINE; QUININE;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG SENSITIVITY; FEMALE; FEVER; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; PARASITEMIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIET NAM;

ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHLOROQUINE; DRUG COMBINATIONS; DRUG THERAPY, COMBINATION; FEMALE; GENOTYPE; HUMANS; MALARIA, FALCIPARUM; MALE; PYRIMETHAMINE; SESQUITERPENES; SULFADOXINE; TREATMENT OUTCOME; VIETNAM;

EID: 10744225417     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/379323     Document Type: Article

References (20)

1. Barradell LB, Fitton A. Artesunate: a review of its pharmacology and therapeutic efficacy in the treatment of malaria. Drugs 1995; 50:714-41.
2. World Health Organization (WHO). Antimalarial drug combination therapy. Report of a WHO Technical Consultation. WHO document no. WHO/CDS/RBM/2001. Geneva: WHO, 2001:35.
3. Nosten F, Brasseur P. Combination therapy for malaria: the way forward? Drugs 2002; 62:1315-29.
4. Phan VT. Epidemiologie du paludisme et lutte antipaludique au Vietnam. Hanoi: Editions Medicales Vietnam, 1998.
5. Nguyen MH, Hewitt S, Davis TME, et al. Resistance of Plasmodium falciparum to antimalarial drugs in a highly endemic area of southern Vietnam: a study in vivo and in vitro. Trans R Soc Trop Med Hyg 2001; 95:325-9.
6. Nosten F, van Vugt M, Price R, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 2000; 356:297-302.
7. World Health Organization (WHO). Chemotherapy of malaria and resistance to anti-malarials. Report of a WHO scientific working group. WHO Technical Report Series 529. Geneva: WHO, 1973:30.
8. Singh B, Cox-Singh J, Miller AO, Abdullah MS, Snounou G, Rahman HA. Detection of malaria in Malaysia by nested polymerase chain reaction amplification of dried blood spots on filter papers. Trans R Soc Trop Med Hyg 1996; 90:519-21.
9. Cox-Singh J, Mahayet S, Abdullah MS, Singh B. Increased sensitivity of malaria detection by nested polymerase chain reaction using simple sampling and DNA extraction. Int J Parasitol 1997; 27:1575-7.
10. Viriyakosol S, Siripoon N, Petcharapirat C, et al. Genotyping of Plasmodium falciparum isolates by the polymerase chain reaction and potential uses in epidemiological studies. Bull WHO 1995; 73:85-95.
11. Snounou G, Zhu X, Siripoon N, et al. Biased distribution of msp1 and msp2 allelic variants in Plasmodium falciparum populations in Thailand. Trans R Soc Trop Med Hyg 1999; 93:369-74.
12. Fidock DA, Nomura T, Talley AK, et al. Mutations in the P. falciparum digestive vacuole transmembrane protein PfCRT and evidence for their role in chloroquine resistance. Molecular Cell 2000; 6:861-71.
13. Djimde A, Doumbo OK, Cortese JF, et al. A molecular marker for chloroquine-resistant falciparum malaria. N Engl J Med 2001; 344: 257-63.
14. Cowman AF. The molecular basis of resistance to the sulfones, sulfonamides and dihydrofolate reductase inhibitors. In: Sherman IW, ed. Malaria: parasite biology, pathogenesis and protection. Washington, DC: ASM, 1998:317-30.
15. Cox-Singh J, Zakaria R, Abdullah MS, Rahman HA, Nagappan S, Singh B. Differences in dihydrofolate reductase but not dihydropteroate synthase alleles in Plasmodium falciparum isolates from geographically distinct areas in Malaysia. Am J Trop Med Hyg 2001; 64:28-31.
16. Duraisingh MT, Curtis J, Warhurst DC. Plasmodium falciparum: DETECTION of polymorphisms in the dihydrofolate reductase and dihydropteroate synthetase genes by PCR and restriction digestion. Exp Parasitol 1998; 89:1-8.
17. World Health Organization (WHO). Assessment of therapeutic efficacy for uncomplicated falciparum malaria in areas of intense transmission. WHO document no. WHO/MAL/96:1077. Geneva: World Health Organization, 1996.
18. Trieu NT, Davis TME, Hewitt S, et al. Treatment of falciparum malaria in Vietnamese children: the need for combination therapy and optimised dosage regimens. Ann Trop Paediatr 2001; 21:307-12.
19. White NJ. The assessment of antimalarial drug efficacy. Trends Parasitol 2002; 18:458-64.
20. World Health Organization (WHO). In vitro micro-test (Mark II) for the assessment of the response of Plasmodium falciparum to chloroquine, quinine, sulfadoxine/pyrimethamine and amodiaquine. Instructions for use of the in vitro micro-test kit (Mark II) and for completing the record form. MAP/87.2. Geneva: WHO, 1987.